Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Albers

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
Neurochemistry International|April 12, 2003
Increased plasma levels of matrix metalloproteinase-9 in patients with Alzheimer's diseaseStefan Lorenzl, David S Albers, Norman Relkin, et al.
Journal of the Neurological Sciences|March 5, 2003
Tissue inhibitors of matrix metalloproteinases are elevated in cerebrospinal fluid of neurodegenerative diseasesS Lorenzl, D S Albers, P A LeWitt, et al.
Investigative Ophthalmology & Visual Science|January 19, 2018
Trabodenoson, an Adenosine Mimetic With A1 Receptor Selectivity Lowers Intraocular Pressure by Increasing Conventional Outflow Facility in MiceGuorong Li, Karen Y Torrejon, Andrea M Unser, et al.
Experimental Neurology|March 22, 2001
Transgenic ALS mice show increased vulnerability to the mitochondrial toxins MPTP and 3-nitropropionic acidO A Andreassen, R J Ferrante, P Klivenyi, et al.
Brain Research|March 7, 2002
Expression and activity of antioxidants in the brain in progressive supranuclear palsyIppolita Cantuti-Castelvetri, Christine E Keller-McGandy, David S Albers, et al.
Neuromolecular Medicine|April 13, 2004
Matrix metalloproteinase-9 is elevated in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in miceStefan Lorenzl, Noel Calingasan, Lichuan Yang, et al.
Neurology|August 15, 2002
Dopamine transmission in DYT1 dystonia: a biochemical and autoradiographical studySarah J Augood, Z Hollingsworth, D S Albers, et al.
Brain Research|February 11, 2003
Age-related microglial activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurodegeneration in C57BL/6 miceShuei Sugama, Lichuan Yang, Byung Pil Cho, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|July 9, 2010
Behavioral symptoms in long-term survivors of ischemic strokeBeth K Rush, Rebecca B McNeil, Dale M Gamble, et al.
Journal of Neuroscience Research|September 30, 2003
Minocycline enhances MPTP toxicity to dopaminergic neuronsLichuan Yang, Shuei Sugama, Jason W Chirichigno, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Neurochemistry International|April 12, 2003
Increased plasma levels of matrix metalloproteinase-9 in patients with Alzheimer's diseaseStefan Lorenzl, David S Albers, Norman Relkin, et al.
Journal of the Neurological Sciences|March 5, 2003
Tissue inhibitors of matrix metalloproteinases are elevated in cerebrospinal fluid of neurodegenerative diseasesS Lorenzl, D S Albers, P A LeWitt, et al.
Investigative Ophthalmology & Visual Science|January 19, 2018
Trabodenoson, an Adenosine Mimetic With A1 Receptor Selectivity Lowers Intraocular Pressure by Increasing Conventional Outflow Facility in MiceGuorong Li, Karen Y Torrejon, Andrea M Unser, et al.
Experimental Neurology|March 22, 2001
Transgenic ALS mice show increased vulnerability to the mitochondrial toxins MPTP and 3-nitropropionic acidO A Andreassen, R J Ferrante, P Klivenyi, et al.
Brain Research|March 7, 2002
Expression and activity of antioxidants in the brain in progressive supranuclear palsyIppolita Cantuti-Castelvetri, Christine E Keller-McGandy, David S Albers, et al.
Neuromolecular Medicine|April 13, 2004
Matrix metalloproteinase-9 is elevated in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in miceStefan Lorenzl, Noel Calingasan, Lichuan Yang, et al.
Neurology|August 15, 2002
Dopamine transmission in DYT1 dystonia: a biochemical and autoradiographical studySarah J Augood, Z Hollingsworth, D S Albers, et al.
Brain Research|February 11, 2003
Age-related microglial activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurodegeneration in C57BL/6 miceShuei Sugama, Lichuan Yang, Byung Pil Cho, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|July 9, 2010
Behavioral symptoms in long-term survivors of ischemic strokeBeth K Rush, Rebecca B McNeil, Dale M Gamble, et al.
Journal of Neuroscience Research|September 30, 2003
Minocycline enhances MPTP toxicity to dopaminergic neuronsLichuan Yang, Shuei Sugama, Jason W Chirichigno, et al.
Pageof 7